Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biocept Inc (NASDAQ:BIOC)

0.5386
Delayed Data
As of 3:59pm ET
 -0.0445 / -7.63%
Today’s Change
0.49
Today|||52-Week Range
2.68
-60.97%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$14.7M

Company Description

Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support. The company was founded on May 12, 1997 and is headquartered in San Diego, CA.

Contact Information

Biocept, Inc.
5810 Nancy Ridge Drive
San Diego California 92121-2840
P:(858) 320-8200
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Michael W. NallPresident, CEO & Class III Director
Raaj TrivediVice President-Commercial Operations
Timothy C. KennedyChief Financial Officer & Senior VP-Operations
Lyle J. ArnoldChief Scientific Officer & SVP-Research
Veena M. SinghSenior Vice President & Senior Medical Director